ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Phoenix, AZ

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus
Diabetes Mellitus
Obesity
Type 1 Diabetes Mellitus
Overweight
Diabetic Foot
Foot Ulcer

Diabetes trials near Phoenix, AZ, USA:

Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus

of this research is to evaluate outcomes of physiologic insulin re-sensitization (PIR) in patients with Chronic Kidney Disease (CKD) and Type 2 Diabetes...

Enrolling
Type 2 Diabetes
Chronic Kidney Disease (Stages 4 and 5)
Other: Physiologic Insulin Resensitization (PIR)
Well Cell Global

Phoenix, Arizona, United States and 1 other location

The purpose of this study is to assess the safety, tolerability and effectiveness of RF vapor ablation of the proximal intestinal mucosa. This study...

Enrolling
Type-2 Diabetes Mellitus
Device: RF Vapor Ablation
Aqua Medical

Scottsdale, Arizona, United States and 3 other locations

Locations recently updated

This study is a Phase 2 clinical trial to evaluate the efficacy, safety, and tolerability of HM15275 in subjects with type 2 diabetes mellit...

Enrolling
Type 2 Diabetes Mellitus
T2DM
Drug: HM15275
Drug: Placebo of HM15275

Phase 2

Hanmi Pharmaceutical
Hanmi Pharmaceutical

Mesa, Arizona, United States and 14 other locations

The main purpose of this study is to learn more about the safety and efficacy of investigational tirzepatide doses in participants with Type 2 diabetes...

Active, not recruiting
Type 2 Diabetes
Obesity
Drug: Tirzepatide
Drug: Placebo

Phase 2

Lilly
Lilly

Phoenix, Arizona, United States of America and 40 other locations

The primary objective of this study is to demonstrate that ribupatide (KAI-9531) subcutaneous (SC) injection once weekly is superior to placebo on:*...

Enrolling
Overweight With Diabetes
Obesity With Diabetes
Drug: Ribupatide
Drug: Placebo

Phase 3

Kailera

Phoenix, Arizona, United States and 115 other locations

Diabetic Retinopathy (DR) is a common eye condition caused by diabetes, where high blood sugar levels damage the blood vessels in t...

Enrolling
Diabetic Retinopathy
Drug: Topical Steroid
Drug: Artificial Tears

Phase 2, Phase 3

AbbVie
AbbVie

Phoenix, Arizona, United States and 23 other locations

This is a Phase 3 trial of cadisegliatin as adjunctive therapy to insulin in participants with Type 1 Diabetes Mellitus....

Active, not recruiting
Diabetes Mellitus, Type 1
Drug: Cadisegliatin 800 mg QD
Drug: Placebo

Phase 3

vTv Therapeutics
vTv Therapeutics

Scottsdale, Arizona, United States of America and 56 other locations

The purpose of this study is to investigate the efficacy and safety of retatrutide compared with placebo in participants with Type 2 Diabetes...

Active, not recruiting
Type 2 Diabetes
Drug: Retatrutide
Drug: Placebo

Phase 3

Lilly
Lilly

Sun City West, Arizona, United States and 78 other locations

Evaluate the Safety, Tolerability, and Efficacy of OTX-TKI in Subjects with Moderately Severe to Severe Non-proliferative Diabetic Retinopat...

Active, not recruiting
Non-proliferative Diabetic Retinopathy
Drug: OTX-TKI
Drug: Sham

Phase 1

Ocular Therapeutix
Ocular Therapeutix

Phoenix, Arizona, United States and 9 other locations

Study ASC30-302 (AURORA-2) is a Phase III, global, multicenter, randomized, double-blind, placebo-controlled study to investigate the long-term effic...

Enrolling
Type 2 Diabetes Mellitus
Overweight
Drug: ASC30 tablets A1
Drug: Placebo

Phase 3

Ascletis Pharma (China) Co., Limited

Phoenix, Arizona, United States and 135 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems